Table 1.
Exercise Test |
Pacing | End Point | Principal Measurement |
Adjunct Measurements |
Intensity | Complexity | Relationship to | Relationship to PA | Relationship to PRO | Relationship to Clinical Outcomes | |
---|---|---|---|---|---|---|---|---|---|---|---|
CPET20 | Externally paced | Prohibitive symptoms or plateau of |
|
, VE, AT, HR, BP, O2 saturation, work | +++ | +++ | – | – | – | – | |
6MWT23,24 | Self-paced | 6-min duration | Distance | HR, BP, O2 saturation, desaturation indices, work | ++ | + | Moderate-strong | Moderate-strong | Weak-moderate | Consistently strong | |
ESWT23,24 | Externally paced | Prohibitive symptoms or 20-min duration | Time | HR, O2 saturation, distance | ++ | ++ | N/A | N/A | N/A | N/A | |
ISWT23,24 | Externally paced | Prohibitive symptoms or 12 total stages | Distance | HR, O2 saturation, VE | ++ | ++ | Strong | Weak-moderate | N/A | Suggestive | |
SCT | Self-paced | Volitional exhaustion or designated height/flights of stairs | Height | HR, O2 saturation, time | ++ | + | Moderate-strong | N/A | N/A | N/A |
Note: In general, not specific to lung cancer.
6MWT, 6-minute walk test; AT, anaerobic threshold; BP, blood pressure; CPET, cardiopulmonary exercise testing; ESWT, endurance shuttle walk test; ISWT, incremental shuttle walk test; HR, heart rate; O2, oxygen; PA, physical activity; PRO, patient-reported outcome; SCT, stair-climbing test; VE, minute ventilation; , oxygen consumption; min, minute.